Sanofi-Aventis Signs MOU With Korean Health Ministry To Invest $55 Million In R&D
This article was originally published in The Pink Sheet Daily
Executive Summary
The current blockbuster-era led by the U.S. is being replaced by an era of specific products developed and made for specific regions, races or countries, Sanofi official says.